Phase 2/3 Study
If you are interested in being a part of the Phase 2/3 ACU193 clinical study please leave your contact information and we will keep you updated on our progress.
If you are interested in being a part of the Phase 2/3 ACU193 clinical study please leave your contact information and we will keep you updated on our progress.
CORPORATE:
427 Park St.
Charlottesville, VA 22902
434-297-1000
CLINICAL OPERATIONS:
clinical@acumen.com